What happened in optometry this week: October 7 - October 11
Catch up on what happened in optometry during the week of October 7-October 11.
Catch up with what Optometry Times shared this week:
MJH Life Sciences acquires EnVision Summit
By Jordana Joy, Associate Editor
MJH Life Sciences has announced its acquisition of the EnVision Summit, an annually-held continuing medical education conference for eye care providers.1 Held in Puerto Rico, the conference will be hosted within MJH’s Physicians’ Education Resource legacy portfolio and will be supported by Optometry Times and Ophthalmology Times, according to a news release.
Immune cells play significant role in suppressing and resolving inflammation from autoimmune uveitis, study reports
By Jordana Joy, Associate Editor
A new study published in The American Journal of Pathology took a deep dive into the role that immune cells play in the resolution of inflammation on the surface of the eye’s lens, specifically in autoimmune uveitis.1 The disease bypasses the eye’s immune privilege and can damage healthy eye tissue.
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO
By Miriam Korik, OD; Justin Kwan, OD, FAAO; and Emily Kaiser Maharjan, Assistant Managing Editor
Myopia isn't just a speciality anymore - odds are, you've seen it in your practice. Justin Kwan, OD, FAAO, who is senior manager of myopia management in CooperVision's professional and academic affairs group, shares his journey to passionate myopia management champion in practice and in industry. Drs. Kwan and Korik discuss the minutia of management; talking to parents about myopia control options, how to set fees, and how to get the word out about the new service in your practice.
Orasis Pharmaceuticals secures financing for commercial launch of presbyopia-correcting drops
By Emily Kaiser Maharjan, Assistant Managing Editor
Orasis Pharmaceuticals secured $78 million in financing to support the commercial launch of pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi), which is a novel corrective eye drop for the treatment of presbyopia in adults.
The pilocarpine solution is a prescription eye drop that can be used daily, or as needed, up to twice per day. The solution demonstrated efficacy 20 minutes after administration and can last up to 8 hours, as measured on day 15, to improve near vision without impacting distance or night vision. Orasis’s presbyopia-correcting drop is a preservative-free formulation of pilocarpine, an established eye care therapeutic, designed to achieve an optimal balance between efficacy, safety, and comfort.
A glasses-wearing kitty?: Getting to know Truffles
By Danielle Crull, ABOM, and Jordana Joy, Associate Editor
Cats wearing glasses are the norm at A Child's Eyes, a glasses dispensary in Mechanicsburg, Pennsylvania. Danielle Crull, ABOM, owns the practice and has the help of Truffles and Gumdrop to help put her pediatric patients at ease when fitting them with glasses or outfitting them with eye patches. For over 5 years, Truffles has taken the internet by storm by spreading the message about children's eye health through a substantial social media following. Get to know her story on Instagram or at her website.
